Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdds the latest revision tag v3.7.0 to the study history and removes the older v3.6.6, updating the historical record of revisions.SummaryDifference0.1%

- Check46 days agoChange DetectedThe revision tag on the page was updated from v3.6.5 to v3.6.6, reflecting a software update to the record history interface.SummaryDifference0.1%

- Check67 days agoChange DetectedThe history shows a new revision entry v3.6.5 added, replacing the previous v3.6.4, indicating a minor update to the record's revision history.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision v3.6.4 was added to the study's history, replacing the previous v3.6.3 and signaling a small update to the record-keeping for this study.SummaryDifference0.1%

- Check103 days agoChange DetectedA new revision entry v3.6.3 was added to the study history, and the previous revision v3.6.2 was removed.SummaryDifference0.1%

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.